The Team
A powerful mix of scientific depth and commercial execution.
We bring decades of expertise, from lab bench to boardroom, to help clients turn validated research into market-ready success.
Dr. Bart De Wever, PhD
Co-founder
Dr. Bart De Wever, a true titan at the intersection of profound scientific discovery and high-stakes corporate strategy. For over 25 years, he has been a relentless force for innovation in the biomedical world, authoring around a hundred peer-reviewed articles and delivering over 500 international presentations along the way. His doctoral research wasn't merely academic; it fundamentally reshaped global safety testing by pioneering reconstructed human tissue models that gained official regulatory acceptance as alternatives to animal testing. This rare talent for turning complex science into market reality is his hallmark. He masterfully guided not one, but two, biomedical companies, SkinEthic and Bonyf, through successful IPOs at the Paris Stock Market, a journey that saw SkinEthic/EpiSkin acquired by the global giant L'Oréal. He is also the author of La Luminothérapie Hyperlight, prefaced by Dr. Deepak Chopra, Prof. Jack Tuszynski and Dr. Fertig, contributing further to the growing field of photobiomodulation.
Jeroom De Wever
Co-founder
Jeroom De Wever brings commercial drive, strategic focus, and a sharp eye for market dynamics. A serial entrepreneur with a strong instinct for early-stage momentum, he specializes in high-level relationship building and connecting scientific value to real-world traction. With a pragmatic mindset and hands-on presence, he ensures that Biodvance’s technical expertise is translated into viable partnerships, market positioning, and commercial results, particularly across biotech, medtech, and emerging life science ventures. His ability to bridge visionary concepts with grounded execution is central to the firm’s commercial engine.
